MX2014008336A - Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. - Google Patents
Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico.Info
- Publication number
- MX2014008336A MX2014008336A MX2014008336A MX2014008336A MX2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A MX 2014008336 A MX2014008336 A MX 2014008336A
- Authority
- MX
- Mexico
- Prior art keywords
- antiallodynic
- antihyperalgesic
- pharmaceutical compositions
- treating
- compositions containing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Abstract
La presente invención se refiere a una novedosa combinación farmacéutica sinérgica de un agente antihiperalgésico, antialodínico y un agente antiinflamatorio, en donde el agente antihiperalgésico, antialodínico es Pregabalina, y el agente antiinflamatorio es Meloxicam. La presente invención además está dirigida a composiciones farmacéuticas que comprenden dicha combinación, y al uso de dicha combinación y composiciones farmacéuticas para la prevención y/o tratamiento del dolor neuropático ocasionado por diversas etiologías.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2014008336A MX2014008336A (es) | 2014-07-07 | 2014-07-07 | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
BR112017000359-7A BR112017000359A2 (pt) | 2014-07-07 | 2015-07-07 | combinação de pregabalina e meloxicam para o tratamento de dor neuropática |
PCT/IB2015/055127 WO2016005897A1 (en) | 2014-07-07 | 2015-07-07 | Combination of pregabalin and meloxicam for the treatment of neuropathic pain |
PE2017000033A PE20171140A1 (es) | 2014-07-07 | 2015-07-07 | Combinacion farmacologica antihiperalgesica, antialodinica y antinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico |
CONC2017/0001076A CO2017001076A2 (es) | 2014-07-07 | 2017-02-06 | Composiciones farmacéuticas antihiperalgésicas, antialodínicas y antiinflamatorias que contienen pregabalina y meloxicam |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2014008336A MX2014008336A (es) | 2014-07-07 | 2014-07-07 | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2014008336A true MX2014008336A (es) | 2016-01-07 |
Family
ID=53938368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014008336A MX2014008336A (es) | 2014-07-07 | 2014-07-07 | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. |
Country Status (5)
Country | Link |
---|---|
BR (1) | BR112017000359A2 (es) |
CO (1) | CO2017001076A2 (es) |
MX (1) | MX2014008336A (es) |
PE (1) | PE20171140A1 (es) |
WO (1) | WO2016005897A1 (es) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112353767A (zh) * | 2020-11-16 | 2021-02-12 | 海南锦瑞制药有限公司 | 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11590094B2 (en) | 2017-09-28 | 2023-02-28 | Nevakar Injectables Inc. | Fixed dose combination formulations for treating pain |
MX2019008467A (es) * | 2019-07-16 | 2019-11-07 | Federico Amezcua Amezcua | Combinacion sinergica de s-ketorolaco y pregabalina en una composicion farmaceutica para el tratamiento del dolor neuropatico. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6129907A (en) | 1999-08-04 | 2000-10-10 | Colgate Palmolive Company | Stable hydrogenated lupulone antibacterial oral compositions |
WO2003066040A1 (fr) | 2002-02-05 | 2003-08-14 | Ajinomoto Co.,Inc. | Compositions medicinales contenant une gabapentine ou une pregabaline et antagoniste a canal de calcium de type n |
DE10331305A1 (de) | 2003-07-10 | 2005-02-17 | Siemens Ag | Kommunikationssystem, Peer-to-Peer-Nachrichten-Filter-Rechner und Verfahren zum Verarbeiten einer Peer-to-Peer-Nachricht |
CA2608010A1 (en) | 2005-05-20 | 2006-11-23 | Pfizer Limited | Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-delta-ligands |
WO2009046801A1 (en) | 2007-10-09 | 2009-04-16 | Merck Patent Gmbh | Pharmaceutical compositions containing benfotiamine and one or one more pharmaceutically active agents for the treatment of pain conditions of neuropathic origin |
BRPI0819451A2 (pt) | 2007-11-23 | 2017-10-03 | Protect Pharmaceutical Corp | Composição farmacêutica, método para tratar dor, kit farmacêutico, e, uso de uma composição |
MX336979B (es) | 2011-12-16 | 2016-02-09 | Senosiain S A De C V Lab | Combinacion farmaceutica antineuritica y composiciones. |
-
2014
- 2014-07-07 MX MX2014008336A patent/MX2014008336A/es unknown
-
2015
- 2015-07-07 PE PE2017000033A patent/PE20171140A1/es unknown
- 2015-07-07 WO PCT/IB2015/055127 patent/WO2016005897A1/en active Application Filing
- 2015-07-07 BR BR112017000359-7A patent/BR112017000359A2/pt not_active Application Discontinuation
-
2017
- 2017-02-06 CO CONC2017/0001076A patent/CO2017001076A2/es unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112353767A (zh) * | 2020-11-16 | 2021-02-12 | 海南锦瑞制药有限公司 | 一种盐酸地尔硫卓和普瑞巴林组合物及其制备方法及其应用 |
Also Published As
Publication number | Publication date |
---|---|
PE20171140A1 (es) | 2017-08-09 |
BR112017000359A2 (pt) | 2018-06-26 |
WO2016005897A1 (en) | 2016-01-14 |
CO2017001076A2 (es) | 2017-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018003472A (es) | Moduladores de la expresion de kras. | |
ZA201701299B (en) | Glycosidase inhibitors | |
BR112018003026A2 (pt) | composições compreendendo um inibidor de pi3k e um inibidor de hdac | |
PH12016502062A1 (en) | Compositions and methods for modulating completent factor b expression | |
SG10201808940WA (en) | Nox inhibitor and nfкb inhibitor containing methoxyflavone | |
PH12017502051A1 (en) | TBK/IKKe INHIBITOR COMPOUNDS AND USES THEREOF | |
UY36014A (es) | ?derivado de pirazol amida, composición farmacéutica y método para tratar o prevenir enfermedades autoinmunes, inflamatorias, metabólicas o cancerosas?. | |
MX2017004808A (es) | Combinaciones que comprenden siponimod y laquinimod para el tratamiento de la esclerosis multiple. | |
CR20190537A (es) | Inhibidores pirazólicos de magl | |
MX2022007436A (es) | Inhibidores de la autotaxina y sus usos. | |
EA201792496A1 (ru) | Способы лечения воспаления или нейропатической боли | |
PH12017500459A1 (en) | Azetidinyloxyphenylpyrrolidine compounds | |
EA201791174A1 (ru) | Антимикотическое соединение | |
EA201891347A1 (ru) | Аза-бензимидазольные ингибиторы pad4 | |
MX2017006709A (es) | Agente para prevenir o mejorar sintomas causados por desequilibrio de las hormonas sexuales. | |
PH12019502174A1 (en) | Modulators of pcsk9 expression | |
TN2018000057A1 (en) | Compounds useful for inhibiting ror-gamma-t. | |
EA201692020A1 (ru) | Пролекарственные средства янтарной кислоты для применения в лечении лактоацидоза или индуцируемого лекарственными средствами побочного действия вследствие связанных с комплексом i нарушений окислительного фосфорилирования в митохондриях | |
MX2017004819A (es) | Metodos de tratamiento de transtornos urológicos usando sarm. | |
MX2014008336A (es) | Combinacion farmacologica antihiperalgesica, antialodinica y antiinflamatoria, composiciones farmaceuticas que la contienen, y su uso para el tratamiento del dolor neuropatico. | |
PH12017501897A1 (en) | 2-thiopyrimidinones | |
MX2018006631A (es) | Compuesto para uso en la prevencion y tratamiento de enfermedades neurodegenerativas. | |
MX2018004532A (es) | Combinacion de trazodona y gabapentina para el tratamiento de dolor. | |
IN2014CH00686A (es) |